& Torekov, S
Therefore, future large, randomized, placebo-controlled trials on the use of semaglutide and tirzepatide are warranted to definitively clarify the long-term safety and efficacy profile of these medications in patients with T1D (at different stages of the disease and treated with or without AID systems) and in patients with LADA
Some people may experience mild side effects such as: Temporary discomfort at the injection site Mild headache Feeling flushed These effects are usually short-lived
Available from: /pmc/articles/PMC9464341/ [DOI] [PMC free article] [PubMed] [Google Scholar] Shahmansouri N, Farokhnia M, Abbasi SH, Kassaian SE, Noorbala Tafti AA, Gougol A, et al
Moreover, these drugs can improve cholesterol, blood pressure, and overall heart health